{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:07:20Z","timestamp":1785215240733,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.micpath.2024.106769","type":"journal-article","created":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T21:44:55Z","timestamp":1719783895000},"page":"106769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Antibiofilm activity of promethazine against ESBL-producing strains of Escherichia coli in urinary catheters"],"prefix":"10.1016","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4964-351X","authenticated-orcid":false,"given":"Cec\u00edlia Rocha","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6408-7200","authenticated-orcid":false,"given":"Vit\u00f3ria Pessoa de Farias","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8496-8243","authenticated-orcid":false,"given":"Daniel Sampaio","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0971-1311","authenticated-orcid":false,"given":"Thais Lima","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4104-5518","authenticated-orcid":false,"given":"Amanda Dias","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Batista","family":"de Andrade Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Alves","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0285-1258","authenticated-orcid":false,"given":"Lara Elloyse Almeida","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1430-1747","authenticated-orcid":false,"given":"\u00c9rica Rayanne Mota","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus Victor Feitosa","family":"de Queiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine Aires","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6384-5754","authenticated-orcid":false,"given":"D\u00e1vylla R\u00eannia Saldanha","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lio Vitoriano","family":"Nobre J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0619-2782","authenticated-orcid":false,"given":"Livia Gurgel do Amaral","family":"Valente S\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2024.106769_bib1","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.2147\/IDR.S325770","article-title":"Characterization of E. coli phylogroups causing catheter-associated urinary tract infection","volume":"14","author":"El-Mahdy","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.micpath.2024.106769_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268820003015","article-title":"Extended - spectrum beta - lactamase Escherichia coli and Klebsiella pneumoniae urinary tract infections","volume":"149","author":"Vachvanichsanong","year":"2021","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.micpath.2024.106769_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-14177-y","article-title":"The impact of the ST131 clone on recurrent ESBL-producing E. coli urinary tract infection: a prospective comparative study","volume":"12","author":"Lindblom","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2024.106769_bib4","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/jac\/dkac063","article-title":"Vancomycin-arginine (STM-001) abrogates ESBL carrier and carbapenem-resistant Escherichia coli burden in a murine complicated urinary tract infection model","volume":"77","author":"Neville","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2024.106769_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/276941","article-title":"Genotyping of ESBL producing uropathogenic Escherichia coli in west of Iran","volume":"2014","author":"Mohajeri","year":"2014","journal-title":"Int. J. Microbiol."},{"key":"10.1016\/j.micpath.2024.106769_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4103\/1755-6783.154823","article-title":"Distribution of ESBL producing Uropathogenic Escherichia coli and carriage of selected \u03b2-lactamase genes in Hospital and community isolates in west of Iran","volume":"7","author":"Mohajeri","year":"2014","journal-title":"Ann. Trop. Med. Publ. Health"},{"key":"10.1016\/j.micpath.2024.106769_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41182-019-0147-8","article-title":"Frequency of quinolone resistance genes among extended-spectrum \u03b2-lactamase (ESBL)-producing Escherichia coli strains isolated from urinary tract infections","volume":"47","author":"Farajzadehsheikh","year":"2019","journal-title":"Trop. Med. Health"},{"key":"10.1016\/j.micpath.2024.106769_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8869275","article-title":"Biofilm-producing bacteria and risk factors (Gender and Duration of Catheterization) Characterized as catheter-associated biofilm formation","volume":"2021","author":"Gunardi","year":"2021","journal-title":"Int. J. Microbiol."},{"key":"10.1016\/j.micpath.2024.106769_bib9","first-page":"1","article-title":"Development of phage Cocktails to Treat E. coli catheter-associated urinary tract infection and associated biofilms","volume":"13","author":"Sanchez","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2024.106769_bib10","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.3390\/microorganisms10091757","article-title":"The Multifunctional Role of Poloxamer P338 as a biofilm disrupter and antibiotic Enhancer: a Small Step forward against the Big Trouble of catheter-associated Escherichia coli urinary tract infections","volume":"10","author":"Henrici De Angelis","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2024.106769_bib11","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jiph.2023.05.026","article-title":"Reduction of biofilm formation of Escherichia coli by targeting quorum sensing and adhesion genes using the CRISPR\/Cas9-HDR approach, and its clinical application on urinary catheter","volume":"16","author":"Alshammari","year":"2023","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.micpath.2024.106769_bib12","first-page":"1","volume":"5","author":"Neupane","year":"2016","journal-title":"Resist. Infect. Control"},{"key":"10.1016\/j.micpath.2024.106769_bib13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3390\/pathogens9110885","article-title":"Poloxamer 338 affects cell adhesion and biofilm formation in Escherichia coli: potential applications in the management of catheter-associated urinary tract infections","volume":"9","author":"Stirpe","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.micpath.2024.106769_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114239","article-title":"Drug repositioning: Progress and challenges in drug discovery for various diseases","volume":"234","author":"Hua","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.micpath.2024.106769_bib15","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.7150\/thno.56205","article-title":"Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.micpath.2024.106769_bib16","article-title":"Current achievements and perspectives in synthesis and applications of 3,7-disubstituted phenothiazines as Methylene Blue analogues","volume":"208","author":"Padnya","year":"2022","journal-title":"Dyes Pigments"},{"key":"10.1016\/j.micpath.2024.106769_bib17","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/jam.15109","article-title":"Antibacterial properties of phenothiazine derivatives against multidrug-resistant Acinetobacter baumannii strains","volume":"131","author":"Aguilar-Vega","year":"2021","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.micpath.2024.106769_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/08927014.2016.1262846","article-title":"Promethazine improves antibiotic efficacy and disrupts biofilms of Burkholderia pseudomallei","volume":"33","author":"Sidrim","year":"2016","journal-title":"Biofouling"},{"key":"10.1016\/j.micpath.2024.106769_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/lambio\/ovad119","article-title":"Antibiofilm activity of promethazine, deferiprone, and Manuka honey in an ex vivo wound model","volume":"76","author":"Guedes","year":"2023","journal-title":"Lett. Appl. Microbiol."},{"key":"10.1016\/j.micpath.2024.106769_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/08927014.2023.2202313","article-title":"Effect of promethazine on biofilms of gram-positive cocci associated with infectious endocarditis","volume":"39","author":"Guedes","year":"2023","journal-title":"Biofouling"},{"key":"10.1016\/j.micpath.2024.106769_bib21","first-page":"1012","article-title":"In vitro effects of promethazine on cell morphology and structure and mitochondrial activity of azole-resistant Candida tropicalis","volume":"56","author":"Brilhante","year":"2018","journal-title":"Med. Mycol."},{"key":"10.1016\/j.micpath.2024.106769_bib22","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/mmy\/myz140","article-title":"Antifungal activity of promethazine and chlorpromazine against planktonic cells and biofilms of Cryptococcus neoformans\/Cryptococcus gattii complex species","volume":"58","author":"Brilhante","year":"2020","journal-title":"Med. Mycol."},{"key":"10.1016\/j.micpath.2024.106769_bib23","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/08927014.2023.2202315","article-title":"Promethazine inhibits efflux, enhances antifungal susceptibility and disrupts biofilm structure and functioning in Trichosporon","volume":"39","author":"Aguiar","year":"2023","journal-title":"Biofouling"},{"key":"10.1016\/j.micpath.2024.106769_bib24","series-title":"The European Committee on Antimicrobial Susceptibility Testing. EUCAST Guidelines for Detection of Resistance Mechanisms and Specific Resistances of Clinical And\/or Epidemiological Importance","first-page":"1","year":"2017"},{"key":"10.1016\/j.micpath.2024.106769_bib25","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard\u2014Tenth Edition. CLSI Document M07-A10","first-page":"1","year":"2015"},{"key":"10.1016\/j.micpath.2024.106769_bib26","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","first-page":"1","year":"2021"},{"key":"10.1016\/j.micpath.2024.106769_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.micpath.2018.11.056","article-title":"A mechanistic approach to the in-vitro resistance modulating effects of fluoxetine against meticillin resistant Staphylococcus aureus strains","volume":"127","author":"Batista de Andrade Neto","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2024.106769_bib28","doi-asserted-by":"crossref","first-page":"7542","DOI":"10.3390\/molecules26247542","article-title":"Composition, anti-MRSA activity and toxicity of essential oils from cymbopogon species","volume":"26","author":"Piasecki","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.micpath.2024.106769_bib29","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.carbpol.2013.09.041","article-title":"A comprehensive study into the impact of a chitosan mouthwash upon oral microorganism's biofilm formation in vitro","volume":"101","author":"Costa","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.micpath.2024.106769_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2015.01.037","article-title":"Biomaterial modification of urinary catheters with antimicrobials to give long-term broadspectrum antibiofilm activity","volume":"202","author":"Fisher","year":"2015","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.micpath.2024.106769_bib31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijmm.2016.05.004","article-title":"Antimicrobial activity of plumbagin, a naturally occurring naphthoquinone from Plumbago rosea, against Staphylococcus aureus and Candida albicans","volume":"306","author":"Nair","year":"2016","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2024.106769_bib32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbrc.2020.12.078","article-title":"D-Serine inhibits the attachment and biofilm formation of methicillin-resistant Staphylococcus aureus","volume":"537","author":"Iwata","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.micpath.2024.106769_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2217\/fmb-2020-0080","article-title":"Evaluation of the antifungal activity in vitro of midazolam against fluconazole-resistant Candida spp. isolates","volume":"16","author":"Holanda","year":"2021","journal-title":"Future Microbiol."},{"key":"10.1016\/j.micpath.2024.106769_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009126","article-title":"Targeting bioenergetics is key to counteracting the drug-tolerant state of biofilm-grown bacteria","volume":"16","author":"Donnert","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2024.106769_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijantimicag.2007.02.019","article-title":"Promethazine renders Escherichia coli susceptible to penicillin G: real-time measurement of bacterial susceptibility by fluoro-luminometry","volume":"30","author":"Lehtinen","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2024.106769_bib36","first-page":"367","article-title":"Synergistic interaction between proton pump inhibitors and resistance modifiers: Promoting effects of antibiotics and plasmid curing","volume":"20","author":"Wolfart","year":"2006"},{"key":"10.1016\/j.micpath.2024.106769_bib37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0924-8579(03)00207-3","article-title":"Enhancement of plasmid curing by 9-aminoacridine and two phenothiazines in the presence of proton pump inhibitor 1-(2-benzoxazolyl)-3,3,3-trifluoro-2-propanone","volume":"22","author":"Spengler","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2024.106769_bib38","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1021\/acsabm.2c00867","article-title":"Mannosylated Gold Nanoclusters Incorporated with a Repurposed antihistamine drug promethazine for antibacterial and antibiofilm applications","volume":"5","author":"Choudhury","year":"2022","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.micpath.2024.106769_bib39","first-page":"276","article-title":"Adhesion properties of E. coli cells in the presence of promethazine","volume":"266","author":"Moln\u00e1r","year":"1987","journal-title":"Zentralbl. Bakteriol. Mikrobiol. Hyg."},{"key":"10.1016\/j.micpath.2024.106769_bib40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0924-8579(00)00130-8","article-title":"Guanine-cytosine rich regions of plasmid DNA can be the target in anti-plasmid effect of phenothiazines","volume":"14","author":"Miskolci","year":"2000","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2024.106769_bib41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/jac\/dkt420","article-title":"Inhibition of multidrug efflux as a strategy to prevent biofilm formation","volume":"69","author":"Baugh","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2024.106769_bib42","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/apm.12675","article-title":"Antifouling and antimicrobial biomaterials: an overview","volume":"125","author":"Francolini","year":"2017","journal-title":"Apmis"},{"key":"10.1016\/j.micpath.2024.106769_bib43","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2217\/fmb-2019-0092","article-title":"Chlorpromazine-impregnated catheters as a potential strategy to control biofilm-associated urinary tract infections","volume":"14","author":"Sidrim","year":"2019","journal-title":"Future Microbiol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401024002365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401024002365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T02:49:52Z","timestamp":1728355792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401024002365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":43,"alternative-id":["S0882401024002365"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2024.106769","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiofilm activity of promethazine against ESBL-producing strains of Escherichia coli in urinary catheters","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2024.106769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106769"}}